The demand for Lipid-Lowering Agents in Moldova has been on the rise in recent years.
Customer preferences: Patients in Moldova are becoming more aware of the importance of managing their cholesterol levels, leading to an increased demand for Lipid-Lowering Agents. Additionally, the aging population in Moldova is also contributing to the growth of the market, as older individuals are more likely to require medication to manage their cholesterol levels.
Trends in the market: The Lipid-Lowering Agents market in Moldova is expected to continue growing in the coming years, driven by the increasing prevalence of lifestyle-related diseases such as obesity and diabetes. As a result, there is a growing need for effective cholesterol-lowering medications. However, the market is also facing challenges such as the availability of cheaper generic drugs and the high cost of newer, more advanced medications.
Local special circumstances: Moldova is a developing country with a relatively low GDP per capita, which means that many individuals may not be able to afford more expensive medications. This has led to a significant demand for generic drugs, which are often more affordable. Additionally, the healthcare system in Moldova is still developing, which can also impact the availability and affordability of medications.
Underlying macroeconomic factors: The growth of the Lipid-Lowering Agents market in Moldova is also influenced by broader macroeconomic factors such as population growth, urbanization, and changes in lifestyle and dietary habits. As the population of Moldova continues to grow and become more urbanized, there is a greater need for effective medications to manage lifestyle-related diseases. Additionally, changes in dietary habits and lifestyle choices can also impact the prevalence of these diseases and the demand for cholesterol-lowering medications.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
